Nor-ursodeoxycholic Acid for Metabolic Dysfunction-associated Steatotic Liver Disease: Is There Enough Evidence for Clinical Use? A Critique of a Phase III Trial and Regulatory Endorsement of the Drug

Authors: Karan Kumar, Vivek Saraswat, Ashish Kumar et al.
Publication: Journal of Clinical and Experimental Hepatology
Published: Jul 1, 2026
Source: Crossref
Back to Search View Original Cite This Article

Related Articles

Need of Hearing Assistance Technology (HAT) for Adults with Hearing Impairment

Satish Kumar, Navneet Gupta et al. - Jun 2106

Read More
Behavioral Screening Tests to Detect Hearing Loss in School Aged Children: A Review

Ratul Dey, Jai Lal Davessar et al. - Jun 2106

Read More
Hearing Screening in Primary School Children: An Overview

Mohit Ojha, Satish Kumar et al. - Jun 2106

Read More
Comparative Study of Efficacy and Safety of Ivabradine Versus Metoprolol in Stable Angina

Mukesh Kumar, Priyanka Kumari et al. - Dec 2051

Read More
Rare Adrenal Gland Emergencies: A Case Series of Giant Myelolipoma Presenting With Massive Hemorrhage and Abscess

Santosh Kumar, Kumar Jayant et al. - Jan 2038

Read More